Fujifilm/Kyowa Kirin biosimilars alliance looks to production cost benefits
This article was originally published in Scrip
Executive Summary
Fujifilm and Kyowa Hakko Kirin have agreed to set up an equally owned Japanese joint venture for the development and commercialisation of biosimilar products, a major aim of which is to come up with innovative, cost-competitive manufacturing processes.